Chemokines, lymphocytes and viruses: What goes around, comes around

Current Opinion in Immunology

Volumn 10, Issue 3, 1998, Pages 265-270

  Nelson, Peter J ^a   Krensky, Alan M ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; REVIEW;

EID: 0031832344     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80164-7     Document Type: Article

References (38)

1. Taub DD. Chemokine - leukocyte interactions. The voodoo that they do so well. of outstanding interest Cytokine Growth Factor Rev. 7:1996;355-376 This is a detailed summary of chemokine - leukocyte interactions. This review contains extensive information on the biology of chemokines and lymphocytes including the modulation of lymphocyte effector activity by chemokines and general information on expression of chemokines in disease.
2. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. of outstanding interest Annu Rev Immunol. 15:1997;675-705 This provides a broad and detailed review of chemokines and chemokine receptors.
3. Mackay CR. Chemokines: what chemokine is that? Curr Biol. 7:1997;R384-R386.
4. Campbell JJ, Foxman EF, Butcher EC. Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration. of special interest Eur J Immunol. 27:1997;2571-2578 The authors show that leukocytes express many receptors for chemotactic factors. The cross-talk between these receptors and their signaling pathways may help target leukocyte migration.
5. Foxman EF, Campbell JJ, Butcher EC. Multistep navigation and the combinatorial control of leukocyte chemotaxis. of outstanding interest J Cell Biol. 139:1997;1349-1360 This paper details the theory that lymphocytes must follow a hierarchy of chemotactic signals as they traffic through tissues.
6. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. of outstanding interest Cell. 87:1996;1037-1047 A knockout of the putative chemokine receptor BLR1 results in a pronounced effect on B-lymphocyte trafficking and the development of secondary lymphoid organs.
7. Yoshie O, Imai T, Nomiyama H. Novel lymphocyte-specific CC chemokines and their receptors. of outstanding interest J Leukocyte Biol. 62:1997;634-644 This review briefly summarizes the field of chemokines and then focuses on the tremendous effort that led to the identification and characterization of the chemokines TARC, LARC, ELC, SLC and PARC and the identification of receptors for TARC, LARC, and ELC.
8. Hromas R, Gray PW, Chantry D, Godiska R, Krathwohl M, Fife K, Bell GI, Takeda J, Aronica S, Gordon M, et al. Cloning and characterization of exodus, a novel beta-chemokine. Blood. 89:1997;3315-3322.
9. Rossi DL, Vicari AP, Franz-Bacon K, McClanahan TK, Zlotnik A. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Immunol. 158:1997;1033-1036.
10. Hedrick JA, Zlotnik A. Identification and characterization of a novel rn chemokine containing six conserved cysteines. J Immunol. 159:1997;1589-1593.
11. Hromas R, Kim CH, Klemsz M, Krathwohl M, Fife K, Cooper S, Schnizlein-Bick C, Broxmeyer HE. Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. J Immunol. 159:1997;2554-2558.
12. Adema GJ, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S, Foster J, Xu Y, Nooyen P, McClanahan T, et al. A dendritic cell-derived C-C chemokine that preferentially attracts naive T cells. Nature. 387:1997;713-717.
13. Power CA, Church DJ, Meyer A, Alouani S, Proudfoot AE, Clark-Lewis I, Sozzani S, Mantovani A, Wells TN. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells. J Exp Med. 186:1997;825-835.
14. Greaves DR, Wang W, Dairaghi DJ, Dieu MC, Saint-Vis B, Franz-Bacon K, Rossi D, Caux C, McClanahan T, Gordon S, et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med. 186:1997;837-844.
15. Godiska R, Chantry D, Raport CJ, Sozzani S, Allavena P, Leviten D, Mantovani A, Gray PW. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med. 185:1997;1595-1604.
16. Chang Ms, McNinch J, Elias C 3rd, Manthey CL, Grosshans D, Meng T, Boone T, Andrew DP. Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytes. J Biol Chem. 272:1997;25229-25237.
17. Coulin F, Power CA, Alouani S, Peitsch MC, Schroeder JM, Moshizuki M, Clark-Lewis I, Wells TN. Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines. Eur J Biochem. 248:1997;507-515.
18. Youn B-S, Zhang SM, Lee EK, Park DH, Broxmeyer HE, Murphy PM, Locati M, Pease JE, Kim KK, Antol K, et al. Molecular cloning of leukotactin-1, a chemoattractant for neutrophils, monocytes and lymphocytes and a potent agonist at CC chemokine receptors 1 and 3. J Immunol. 159:1998;5201-5205.
19. Patel VP, Kreider BL, Li Y, Li H, Leung K, Salcedo T, Nardelli B, Pippalla V, Gentz S, Thotakura R, et al. Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med. 185:1997;1163-1172.
20. White JR, Imburgia C, Dul E, Appelbaum E, O'Donnell K, O'Shannessy DJ, Brawner M, Fornwald J, Adamou J, Elshourbagy NA, et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukocyte Biol. 62:1997;667-675.
21. Vicari AP, Figueroa DJ, Hedrick JA, Foster JS, Singh KP, Menon S, Copeland NG, Gilbert DJ, Jenkins NA, Bacon KB, et al. TECK a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Immunity. 7:1997;291-301.
22. Bonini JA, Martin SK, Dralyuk F, Roe MW, Philipson LH, Steiner DF. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. DNA Cell Biol. 16:1997;1249-1256.
23. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 91:1997;521-530.
24. + T cells are shown to express CCR3, suggesting that the expression of specific chemokine receptors may be a useful tool for further defining lymphocyte effector subsets.
25. Oravecz T, Pall M, Roderiquez G, Gorrell MD, Ditto M, Nguyen NY, Boykins R, Unsworth E, Norcross MA. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. of outstanding interest J Exp Med. 186:1997;1865-1872 The authors show that proteolytic cleavage can act as an additional level of control of the selectivity of cell and chemokine receptor responses.
26. Moore JP, Trkola A, Dragic T. Co-receptors for HIV-1 entry. of outstanding interest Curr Opin Immunol. 9:1997;551-562 A recent review of the field of chemokine receptors and the biology of HIV-1 gives a great summary and perspective of the avalanche of information published in the past few years on this subject.
27. Landau NR. HIV co-receptor identification: good or bad news for drug discovery? of special interest Curr Opin Immunol. 9:1997;628-630 This review deals with the fundamental role of the chemokine receptor CCR5 in the biology of HIV-1 and AIDS and argues that CCR5 should be a good target for HIV-1 therapy.
28. Pal R, Garzino-Demo A, Markham PD, Burns J, Brown M, Gallo RC, DeVico AL. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science. 278:1997;695-698.
29. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL, Siani MA, Sasaki T, Williams TJ, Gray PW, et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science. 278:1997;290-294.
30. Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, Power CA, Luttichau HR, Gerstoft J, Clapham PR, et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science. 277:1997;1656-1659.
31. Smith CA, Smith TD, Smolak PJ, Friend D, Hagen H, Gerhart M, Park L, Pickup DJ, Torrance D, Mohler K, et al. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology. 236:1997;316-327.
32. Krathwohl MD, Hromas R, Brown DR, Broxmeyer HE, Fife KH. Functional characterization of the C - C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2. Proc Natl Acad Sci USA. 94:1997;9875-9880.
33. Lalani AS, McFadden G. Secreted poxvirus chemokine binding proteins. J Leukocyte Biol. 62:1997;570-576.
34. Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM, Schwartz TW, Buser R, Wells TNC, Proudfoot AE. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. of special interest Science. 276:1997;276-279 This demonstrates that the reagent AOP-RANTES is an extremely efficient antagonist of infection by monocytropic strains of HIV-1.
35. Chen JD, Bai X, Yang AG, Cong Y, Chen SY. Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy. of special interest Nature Med. 3:1997;1110-1116 This is the first description of the 'intrakine' approach for the selective suppression of chemokine receptors through genetic engineering of target cells.
36. Yang AG, Bai X, Huang XF, Yao C, Chen S. Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic for HIV-1 infection. Proc Natl Acad Sci USA. 94:1997;11567-11572.
37. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med. 187:1998;655-660.
38. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1) and Th2s. J Exp Med. 187:1998;129-134.